23 Jul Advarra
James Riddle, Vice President, Research Services & Strategic Consulting
Advarra advances the way cell and gene therapy clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted institutional review board and Institutional Biosafety review solutions, innovative clinical trial enablement technologies, experienced bio-safety consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,000 sponsors, CROs, institutions, academic medical centers, and research consortia. Advarra is advancing cell and gene therapy clinical trials to make them safer, smarter, and faster.